TAPSE/RVSP ratio as an echocardiographic marker of residual risk in HFrEF patients receiving vericiguat

11 December 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Understanding the pathophysiology of heart failure Imaging of Heart Failure EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

ESC 365 is supported by

ESC 365 is supported by